🔎 Trials Near Me

Utama › Kanser Paru-paru Bukan Sel Kecil › California › Torrance

Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Torrance, CA

11 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Torrance (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Mengambil pesertaFasa 3
  • Torrance Memorial Physician Network - Cancer Care, Torrance
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT07388524

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Mengambil pesertaFasa 3
  • Torrance Memorial Physician Network - Cancer Care, Torrance
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06498635

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Cancer and Blood Specialty Clinic, Torrance
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07222566

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

Mengambil pesertaKajian pemerhatian
  • Torrance Memorial Physician Network-Cancer Care, Torrance
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07028489

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Mengambil pesertaFasa 3
  • Clinical Study Site, Torrance
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06767514

Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer

Mengambil pesertaFasa 1
  • Cedars-Sinai Cancer at Hunt Cancer Center - TMPNCC, Torrance
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT05401110

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Mengambil pesertaFasa 1
  • Cancer AND Blood Specialty Clinic, Torrance
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Jul 2026 · NCT04389632

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Torrance Memorial Physician Network - Cancer Care, Torrance
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2/3
  • City of Hope South Bay, Torrance
  • Torrance Memorial Physician Network - Cancer Care, Torrance
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Torrance Memorial Physician Network - Cancer Care, Torrance
18 Minutes · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06031688

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

Mengambil pesertaFasa 2
  • City of Hope South Bay, Torrance
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Apr 2026 · NCT07288034

Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain

Kajian lain di Torrance

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.